I A Sesterhenn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I A Sesterhenn

Showing results (101-110 of 103) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 103 results.

Prostate Cancer and Prostatic Diseases|February 21, 2012

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progressionC A Derosa, B Furusato, S Shaheduzzaman, et al.

Human Pathology|February 15, 2001

Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologistsW C Allsbrook, K A Mangold, M H Johnson, et al.

Oncogene|June 11, 2008

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiationC Sun, A Dobi, A Mohamed, et al.

Pageof 11

Search research articles

Showing results (101-110 of 103) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 103 results.

Prostate Cancer and Prostatic Diseases|February 21, 2012

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progressionC A Derosa, B Furusato, S Shaheduzzaman, et al.

Human Pathology|February 15, 2001

Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologistsW C Allsbrook, K A Mangold, M H Johnson, et al.

Oncogene|June 11, 2008

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiationC Sun, A Dobi, A Mohamed, et al.

Pageof 11